Cortisone acetateCAS# 50-04-4 |
2D Structure
- CZC24832
Catalog No.:BCC1507
CAS No.:1159824-67-5
- PI3Kγ inhibitor 1
Catalog No.:BCC4180
CAS No.:1172118-03-4
- CAL-130
Catalog No.:BCC1440
CAS No.:1431697-74-3
- A-443654
Catalog No.:BCC1321
CAS No.:552325-16-3
- CAL-101 (Idelalisib, GS-1101)
Catalog No.:BCC1270
CAS No.:870281-82-6
- BKM120
Catalog No.:BCC1279
CAS No.:944396-07-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 50-04-4 | SDF | Download SDF |
PubChem ID | 5745 | Appearance | Powder |
Formula | C23H30O6 | M.Wt | 402.48 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in DMSO > 10 mM | ||
Chemical Name | [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | ||
SMILES | CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O | ||
Standard InChIKey | ITRJWOMZKQRYTA-RFZYENFJSA-N | ||
Standard InChI | InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h10,16-17,20,28H,4-9,11-12H2,1-3H3/t16-,17-,20+,21-,22-,23-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Cortisone acetate Dilution Calculator
Cortisone acetate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4846 mL | 12.423 mL | 24.846 mL | 49.6919 mL | 62.1149 mL |
5 mM | 0.4969 mL | 2.4846 mL | 4.9692 mL | 9.9384 mL | 12.423 mL |
10 mM | 0.2485 mL | 1.2423 mL | 2.4846 mL | 4.9692 mL | 6.2115 mL |
50 mM | 0.0497 mL | 0.2485 mL | 0.4969 mL | 0.9938 mL | 1.2423 mL |
100 mM | 0.0248 mL | 0.1242 mL | 0.2485 mL | 0.4969 mL | 0.6211 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Cortisone acetate (17-hydroxy-11-dehydrocorticosterone), a 21-carbon steroid hormone, is one of the main hormones released by the adrenal gland in response to stress.
- Dexamethasone (DHAP)
Catalog No.:BCC1184
CAS No.:50-02-2
- Guanidine HCl
Catalog No.:BCC4785
CAS No.:50-01-1
- Tioxolone
Catalog No.:BCC2316
CAS No.:4991-65-5
- 2,4-Pyridinedicarboxylic Acid
Catalog No.:BCC6483
CAS No.:499-80-9
- 5-Isopropyl-2-methylphenol
Catalog No.:BCN2633
CAS No.:499-75-2
- beta-Thujaplicin
Catalog No.:BCN3895
CAS No.:499-44-5
- IsoMaltose
Catalog No.:BCN8321
CAS No.:499-40-1
- Corydamine
Catalog No.:BCN3366
CAS No.:49870-84-0
- Erythroskyrin
Catalog No.:BCN1836
CAS No.:4987-27-3
- EX 527 (SEN0014196)
Catalog No.:BCC2223
CAS No.:49843-98-3
- Tobramycin Sulfate
Catalog No.:BCC5633
CAS No.:49842-07-1
- Ethyl Nipecotate
Catalog No.:BCC3272
CAS No.:5006-62-2
- Mitomycin C
Catalog No.:BCC2388
CAS No.:50-07-7
- Ergocalciferol
Catalog No.:BCN2208
CAS No.:50-14-6
- Cyclophosphamide
Catalog No.:BCC1185
CAS No.:50-18-0
- Corticosterone
Catalog No.:BCN2203
CAS No.:50-22-6
- Hydrocortisone
Catalog No.:BCN2192
CAS No.:50-23-7
- Prednisolone
Catalog No.:BCC4830
CAS No.:50-24-8
- Estriol
Catalog No.:BCN2235
CAS No.:50-27-1
- beta-Estradiol
Catalog No.:BCN2194
CAS No.:50-28-2
- Phenylbutazone
Catalog No.:BCC4822
CAS No.:50-33-9
- Thalidomide
Catalog No.:BCC2248
CAS No.:50-35-1
- Cocaine
Catalog No.:BCN1901
CAS No.:50-36-2
- Clomiphene citrate
Catalog No.:BCC4480
CAS No.:50-41-9
Cyclic utilization of HP-beta-CD in the bioconversion of cortisone acetate by Arthrobacter simplex.[Pubmed:26704767]
Biotechnol Lett. 2016 Apr;38(4):597-602.
OBJECTIVE: To establish a method for the recovery and reutilization of hydroxypropyl-beta-cyclodextrin (HP-beta-CD) to lower the cost of its industrial application in Cortisone acetate bioconversion. RESULTS: HP-beta-CD is not degraded by Arthrobacter simplex CPCC140451 (ASP) resting cells and 96.4 % HP-beta-CD could be recovered by isobutyl acetate extraction. Moreover, the inclusion ability of recovered HP-beta-CD barely decreased. The saccharide metabolic and catalytic activities of ASP were greater in the aqueous phase after extracting with isobutyl acetate than other organic solvents. Cyclic utilization tests showed that Cortisone acetate conversion ratio was 91.0 % after eight cycles and reached 95.7 % with 0.2-0.6 mM HP-beta-CD. Furthermore, >90 % conversion ratio was reached per cycle through a co-cyclic-utilization method with HP-beta-CD and immobilized ASP. CONCLUSION: Cortisone acetate conversion ratio in the HP-beta-CD cyclic-utilization method is promising for industrial applications. The method can also be expanded to other CDs and other hydrophobic compounds bioconversion.
Carbon isotope ratio analysis of endogenous glucocorticoid urinary metabolites after cortisone acetate and adrenosterone administration for doping control.[Pubmed:22987608]
Drug Test Anal. 2012 Dec;4(12):951-61.
Glucocorticoids are listed on the World Anti-Doping Agency (WADA) Prohibited List of substances. The detection of the administration of hydrocortisone and cortisone is complicated by the fact that the human body also produces these steroids naturally. Gas chromatography-combustion-isotope ratio mass spectrometry can be utilized to determine the use of endogenous glucocorticoids by measuring the carbon isotope ratio (CIR) of their resulting metabolites in human urine samples. A comprehensive sample preparation protocol for the analysis of endogenous glucocorticoid urinary metabolites was developed and validated, incorporating the use of high performance liquid chromatography (HPLC) for purification and chemical oxidation for derivatisation. Target compounds were tetrahydrocortisol and tetrahydrocortisone, and 11beta-hydroxyetiocholanolone, 11-oxoetiocholanolone and 11beta-hydroxyandrosterone, while pregnanediol functioned as the endogenous reference compound. Urine samples from a population of 50 volunteers were analyzed to determine CIR reference limits. Excretion studies of the endogenous glucocorticoid preparation Cortisone acetate (25 mg oral) and the dietary supplement adrenosterone (75 mg oral) were conducted with six male individuals. Variable changes in steroid metabolite isotopic composition were found across subjects after administration. The study also revealed that CIR analysis of the major glucocorticoid metabolites tetrahydrocortisol and tetrahydrocortisone is necessary to unambiguously distinguish administration of cortisone and adrenosterone, the former officially restricted to out-of-competition use by athletes, the latter not being restricted at the current time. Moreover, this study reaffirms that CIR methods for the doping control of endogenous steroids should not rely upon a single ERC, as the administration of an appropriate precursor to that ERC could cause complications during analysis.
Photocatalytic decomposition of cortisone acetate in aqueous solution.[Pubmed:24953705]
J Hazard Mater. 2015 Jan 23;282:208-15.
The photocatalytic decomposition of cortisone 21-acetate (CA), a model compound for the commonly used steroid, cortisone, was studied. CA was photocatalytically decomposed in a slurry reactor with the initial rates between 0.11 and 0.46 mg L(-1)min(-1) at 10 mg L(-1) concentration, using the following heterogeneous photocatalysts in decreasing order of their catalytic activity: ZnO>Evonik TiO2 P25>Hombikat TiO2>WO3. Due to the lack of ZnO stability in aqueous solutions, TiO2 P25 was chosen for further experiments. The decomposition reaction was found to be pseudo-first order and the rate constant decreased as a function of increasing initial CA concentration. Changing the initial pH of the CA solution did not affect the reaction rate significantly. The decomposition reaction in the presence of the oxidizing sacrificial agent sodium persulfate showed an observed decomposition rate constant of 0.004 min(-1), lower than that obtained for TiO2 P25 (0.040 min(-1)). The highest photocatalytic degradation rate constant was obtained combining both TiO2 P25 and S2O8(2-) (0.071 min(-1)) showing a synergistic effect. No reactive intermediates were detected using LC-MS showing fast photocatalytic decomposition kinetics of CA.
Construction of engineered Arthrobacter simplex with improved performance for cortisone acetate biotransformation.[Pubmed:24037307]
Appl Microbiol Biotechnol. 2013 Nov;97(21):9503-14.
Arthrobacter simplex 156 is a microorganism that is used for steroid drug biotransformation of Cortisone acetate (CA) to prednisone acetate (PA). The enzyme 3-ketosteroid- big up tri, open(1)-dehydrogenase encoded by the ksdD gene plays an important role in the bioconversion process. To further improve the biotransformation efficiencies of the industrial strain, a genetic manipulation system for A. simplex 156 was developed. Additional copies of the ksdD gene under the control of the cat promoter (from pXMJ19) were transferred into the strain A. simplex 156 and integrated into the 16S rDNA sites, yielding a series of recombinant strains. One of these recombinant strains, designated A. simplex M158, exhibited superior properties for CA biotransformation. At the substrate concentration of 83.6 g/l, the highest PA production of the recombinant strain reached 66.7 g/l, which is approximately 32.9 % higher than that of wild-type strains, and the incubation time for CA to PA bioconversion was reduced by 20 h. Southern blotting analysis of the recombinant strain indicated two copies of deregulated ksdD genes were integrated into the 16S rDNA sites, which means two of five 16S rRNA operons were insertionally disrupted in the recombinant strain. However, the disruption of the two 16S rRNA operons did not affect the growth rate of the recombinant strain, which survived and thrived under desired conditions. In addition, the new strain was genetically stable for more than 100 generations without the use of antibiotics for selection. These superior characteristics make the new strain more suitable than the wild-type strain for PA production.